BioSpace News Archive

Pharvaris To Present at the 2023 HAEi Regional Conference EMEA

Pharvaris, a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema attacks, announced the acceptance of three abstracts for presentation at the HAEi Regional Conference EMEA, taking place in Munich from September 1-3, 2023.

August 23, 2023
·
1 min read
TechBio Innovator Etcembly Reveals World’s First Generative AI-designed Bispecific T Cell Engager With Picomolar Affinity

British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class T cell receptor therapeutics designed using generative AI.

August 23, 2023
·
2 min read
Business

Innovent Announces 2023 Interim Results and Business Updates

Innovent Biologics, Inc. announces its 2023 interim results and major company business updates.

August 23, 2023
·
12 min read
Deals

electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic and wellness company, today announced that it has been completely vindicated in the securities class actions over the company’s 2018 initial public offering brought in the federal and state courts of New Jersey.

August 23, 2023
·
4 min read
Biotech Beach

Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

Organovo Holdings, Inc. (Nasdaq: ONVO) (Organovo) today announced more details about its clinical program for FXR314, an FXR agonist that has completed initial clinical trials.

August 23, 2023
·
4 min read
Pharm Country

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

Baudax Bio, Inc. announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series C Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on September 5, 2023.

August 23, 2023
·
6 min read
Drug Development

Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis

Lynk Pharmaceuticals Co., Ltd. (referred to as “Lynk Pharmaceuticals”), an innovative clinical stage company, announced positive topline data from a Phase II clinical trial of LNK01001 for the treatment of ankylosing spondylitis (AS).

August 23, 2023
·
4 min read
Business

Biorem Reports Second Quarter Results and Record Order Backlog

BIOREM Inc. today announced its results for the three and six-month periods ended June 30, 2023.

August 23, 2023
·
3 min read
Biotech Beach

Cue Health to Present at Upcoming Investor Conferences

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences.

August 23, 2023
·
1 min read
Biotech Beach

Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor

Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring system.

August 23, 2023
·
9 min read